[123I] I-(HE)3-G3

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug Name[123I] I-(HE)3-G3

Drug Alias NameIodine -123-labelled Designed Ankyrin Repeat Proteins HE3-G3

ClassificationBiologics > Protein drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 123I +[4]

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A